Close
Back to VTVT Stock Lookup

vTv Therapeutics (VTVT) –

Jul 2, 2024 04:42 PM Form 8-K vTv Therapeutics Inc. For: Jun 26
Jun 27, 2024 05:39 PM Form 4 vTv Therapeutics Inc. For: Jun 25 Filed by: 667, L.P.
Jun 27, 2024 04:40 PM Form 4 vTv Therapeutics Inc. For: Jun 25 Filed by: SPIEGELMAN DANIEL K
Jun 27, 2024 04:39 PM Form 4 vTv Therapeutics Inc. For: Jun 25 Filed by: Al-Marzooqi Fahed
Jun 27, 2024 04:37 PM Form 4 vTv Therapeutics Inc. For: Jun 25 Filed by: Phillips Anne M.
Jun 24, 2024 04:08 PM vTv Therapeutics (VTVT) Announces Screening of First Patient in CATT1 Pivotal Trial Evaluating Cadisegliatin for Type 1 Diabetes
Jun 24, 2024 04:05 PM vTv Therapeutics Announces Screening of First Patient in CATT1 Pivotal Trial Evaluating Cadisegliatin for Type 1 Diabetes
Jun 13, 2024 06:23 PM Form 4 vTv Therapeutics Inc. For: Feb 27 Filed by: AKKARAJU SRINIVAS
Jun 13, 2024 04:42 PM Form 4 vTv Therapeutics Inc. For: Feb 27 Filed by: Al-Marzooqi Fahed
Jun 13, 2024 04:40 PM Form 4 vTv Therapeutics Inc. For: Feb 27 Filed by: SEKHRI PAUL J
Jun 13, 2024 04:39 PM Form 4 vTv Therapeutics Inc. For: Feb 27 Filed by: Tuch Steven L.
Jun 13, 2024 04:37 PM Form 4 vTv Therapeutics Inc. For: Mar 13 Filed by: Phillips Anne M.
Jun 13, 2024 04:29 PM Form 3 vTv Therapeutics Inc. For: Jun 11 Filed by: SPIEGELMAN DANIEL K
May 28, 2024 08:00 AM CANTEX PHARMACEUTICALS ANNOUNCES FOUR ABSTRACTS TO BE PRESENTED FEATURING AZELIRAGON AT 2024 ASCO ANNUAL MEETING
May 20, 2024 12:00 PM CANTEX PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR AZELIRAGON FOR THE TREATMENT OF PANCREATIC CANCER
May 9, 2024 06:21 PM vTv Therapeutics (VTVT) Misses Q1 EPS by 117c
May 9, 2024 04:51 PM vTv Therapeutics Announces 2024 First Quarter Financial Results and Provides Corporate Update
May 9, 2024 04:33 PM Form 10-Q vTv Therapeutics Inc. For: Mar 31
May 9, 2024 04:28 PM Form 8-K vTv Therapeutics Inc. For: May 09
Apr 30, 2024 06:09 AM Form EFFECT vTv Therapeutics Inc.
Apr 29, 2024 04:30 PM Form 424B2 vTv Therapeutics Inc.
Apr 29, 2024 04:27 PM Form 424B2 vTv Therapeutics Inc.
Apr 25, 2024 04:24 PM Form DEF 14A vTv Therapeutics Inc. For: Jun 11
Apr 10, 2024 05:11 PM Form S-3 vTv Therapeutics Inc.
Mar 26, 2024 04:37 PM vTv Therapeutics (VTVT) Regains Nasdaq Compliance
Mar 26, 2024 04:36 PM Form 8-K vTv Therapeutics Inc. For: Mar 25
Mar 22, 2024 04:57 PM Form SC 13D/A vTv Therapeutics Inc. Filed by: MacAndrews & Forbes Inc.
Mar 19, 2024 08:30 AM CANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMIT
Mar 14, 2024 08:01 AM Form 3 vTv Therapeutics Inc. For: Mar 13 Filed by: Phillips Anne M.
Mar 14, 2024 07:58 AM Form 8-K vTv Therapeutics Inc. For: Mar 13
Mar 13, 2024 08:00 AM vTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
Mar 13, 2024 07:59 AM Form 10-K vTv Therapeutics Inc. For: Dec 31
Mar 13, 2024 07:52 AM Form 8-K vTv Therapeutics Inc. For: Mar 13
Mar 7, 2024 04:53 PM Form 4 vTv Therapeutics Inc. For: Mar 05 Filed by: 667, L.P.
Mar 7, 2024 04:50 PM Form 3 vTv Therapeutics Inc. For: Feb 27 Filed by: 667, L.P.
Mar 7, 2024 04:48 PM Form 3 vTv Therapeutics Inc. For: Feb 27 Filed by: Cheong Raymond
Mar 7, 2024 02:34 PM Form D vTv Therapeutics Inc.
Mar 5, 2024 07:53 PM Form SC 13D vTv Therapeutics Inc. Filed by: Samsara BioCapital, L.P.
Mar 5, 2024 04:25 PM Form SC 13D vTv Therapeutics Inc. Filed by: BAKER BROS. ADVISORS LP
Mar 5, 2024 08:05 AM Form 8-K vTv Therapeutics Inc. For: Mar 05
Mar 4, 2024 08:00 AM vTv Therapeutics (VTVT) Announces FDA Submission for First Phase 3 Study of Cadisegliatin
Mar 4, 2024 08:00 AM vTv Therapeutics Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients with Type 1 Diabetes
Mar 1, 2024 08:00 AM vTv Therapeutics to Participate at the TD Cowen 44th Annual Healthcare Conference
Feb 29, 2024 07:35 PM Form 3 vTv Therapeutics Inc. For: Feb 27 Filed by: Samsara BioCapital, L.P.
Feb 29, 2024 07:34 PM Form 4 vTv Therapeutics Inc. For: Feb 27 Filed by: AKKARAJU SRINIVAS
Feb 29, 2024 07:32 PM Form 3 vTv Therapeutics Inc. For: Feb 23 Filed by: AKKARAJU SRINIVAS
Feb 28, 2024 04:33 PM U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.06%
Feb 28, 2024 09:27 AM Form 8-K vTv Therapeutics Inc. For: Feb 28
Feb 28, 2024 09:14 AM Form 424B5 vTv Therapeutics Inc.
Feb 28, 2024 08:09 AM Form 8-K vTv Therapeutics Inc. For: Feb 23

Back to VTVT Stock Lookup